... on the diseaseactivity score, the use of this score represents a handicap for the evaluation of the efficacy of cyclosporin A on disease activ-ity. On the other hand, cyclosporin A inhibits the ... efficienttreatment of RA in Spain. Throughout the follow-up of the EMECAR cohort, the percentage of patients without anyDMARD declined while the frequency of patients on combined therapy increased. ... Gerards AH, Landewe RB, Prins AP, Bruyn GA, Goei The HS,Laan RF, Dijkmans BA: Cyclosporin A monotherapy versuscyclosporin A and methotrexate combination therapy inpatients with early rheumatoid...